PEBP1 and prostate carcinoma: Initially, the phosphorylated form of RKIP (pS153) indicative of Raf-1 activation was detected in association with centrosomes and prophase/prometaphase kinetochores in a number of cells and tissues including prostate cancer cells, brain hippocampus, and head and neck tumor tissues.